These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 10507778

  • 1. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
    Werle B, Lötterle H, Schanzenbächer U, Lah TT, Kalman E, Kayser K, Bülzebruck H, Schirren J, Krasovec M, Kos J, Spiess E.
    Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
    [Abstract] [Full Text] [Related]

  • 2. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
    Werle B, Kotzsch M, Lah TT, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M, Harbeck N.
    Anticancer Res; 2004 Oct; 24(6):4147-61. PubMed ID: 15736466
    [Abstract] [Full Text] [Related]

  • 3. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
    Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, Turk V, Kos J.
    Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
    [Abstract] [Full Text] [Related]

  • 4. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
    Werle B, Kraft C, Lah TT, Kos J, Schanzenbächer U, Kayser K, Ebert W, Spiess E.
    Cancer; 2000 Dec 01; 89(11):2282-91. PubMed ID: 11147599
    [Abstract] [Full Text] [Related]

  • 5. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
    Werle B, Jülke B, Lah T, Spiess E, Ebert W.
    Br J Cancer; 1997 Dec 01; 75(8):1137-43. PubMed ID: 9099961
    [Abstract] [Full Text] [Related]

  • 6. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
    Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT.
    Mod Pathol; 2000 Nov 01; 13(11):1167-72. PubMed ID: 11106072
    [Abstract] [Full Text] [Related]

  • 7. Changes in plasminogen activator inhibitor-1 levels in non-small cell lung cancer.
    Pavey SJ, Marsh NA, Ray MJ, Butler D, Dare AJ, Hawson GA.
    Boll Soc Ital Biol Sper; 1996 Nov 01; 72(11-12):331-40. PubMed ID: 9178585
    [Abstract] [Full Text] [Related]

  • 8. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful?
    Mori M, Kohli A, Baker SP, Savas L, Fraire AE.
    Mod Pathol; 1997 Jun 01; 10(6):572-7. PubMed ID: 9195574
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 10. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May 01; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 11. Increased cathepsin B activity in human lung tumors.
    Krepela E, Kasafírek E, Novák K, Viklický J.
    Neoplasma; 1990 May 01; 37(1):61-70. PubMed ID: 2320181
    [Abstract] [Full Text] [Related]

  • 12. Activity and tissue localization of cathepsin D in non small cell lung cancer.
    Chyczewski L, Płoński A, Chyczewska E, Furman M, Ostrowska H, Nikliński J, Kozłowski M.
    Rocz Akad Med Bialymst; 1997 May 01; 42 Suppl 1():217-29. PubMed ID: 9337539
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL.
    Br J Cancer; 2000 Apr 01; 82(8):1427-32. PubMed ID: 10780522
    [Abstract] [Full Text] [Related]

  • 14. Tumour CEA as predictor of better outcome in squamous cell carcinoma of the lung.
    Veronesi G, Pelosi G, Sonzogni A, Leon ME, D'Aiuto M, Gasparri R, De Braud F, De Pas T, Sandri M, Spaggiari L.
    Lung Cancer; 2005 May 01; 48(2):233-40. PubMed ID: 15829323
    [Abstract] [Full Text] [Related]

  • 15. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A, Bertacca G, Buttitta F, Chella A, Quattrocolo G, Angeletti CA, Bevilacqua G.
    Clin Cancer Res; 1999 Aug 01; 5(8):2077-81. PubMed ID: 10473089
    [Abstract] [Full Text] [Related]

  • 16. Cystatins in non-small cell lung cancer: tissue levels, localization and relation to prognosis.
    Werle B, Schanzenbächer U, Lah TT, Ebert E, Jülke B, Ebert W, Fiehn W, Kayser K, Spiess E, Abrahamson M, Kos J.
    Oncol Rep; 2006 Oct 01; 16(4):647-55. PubMed ID: 16969475
    [Abstract] [Full Text] [Related]

  • 17. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
    Hoikkala S, Pääkkö P, Soini Y, Mäkitaro R, Kinnula V, Turpeenniemi-Hujanen T.
    Cancer Lett; 2006 May 08; 236(1):125-32. PubMed ID: 15982804
    [Abstract] [Full Text] [Related]

  • 18. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.
    Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lehmann S, Solèr M, Stulz P, Mihatsch MJ, Gudat F.
    J Pathol; 1996 Jan 08; 178(1):53-8. PubMed ID: 8778317
    [Abstract] [Full Text] [Related]

  • 19. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung.
    Huang CI, Taki T, Higashiyama M, Kohno N, Miyake M.
    Br J Cancer; 2000 Jan 08; 82(2):374-80. PubMed ID: 10646891
    [Abstract] [Full Text] [Related]

  • 20. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival.
    Brabender J, Usadel H, Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Hölscher AH, Meltzer SJ, Danenberg PV.
    Oncogene; 2001 Jun 14; 20(27):3528-32. PubMed ID: 11429699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.